Suppr超能文献

疫苗不良事件报告系统中接种疫苗后发生的绒毛膜羊膜炎。

Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System.

作者信息

Datwani Hema, Moro Pedro L, Harrington Theresa, Broder Karen R

机构信息

Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Zoonotic and Emerging Infectious Diseases (NCZEID), Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, United States.

Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Zoonotic and Emerging Infectious Diseases (NCZEID), Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, United States.

出版信息

Vaccine. 2015 Jun 17;33(27):3110-3. doi: 10.1016/j.vaccine.2015.04.097. Epub 2015 May 11.

Abstract

BACKGROUND

In October 2012, the Advisory Committee on Immunization Practices (ACIP) recommended a dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) during each pregnancy, irrespective of the woman's prior history of receiving Tdap. A retrospective cohort study to assess the safety of Tdap vaccination in pregnant women in two Vaccine Safety Datalink (VSD) sites during 2010-2012 found a small but statistically significant increased risk of chorioamnionitis.

OBJECTIVE

We conducted a review of the VAERS database to describe reports of chorioamnionitis following receipt of any vaccines.

METHODS

We searched the VAERS database for reports of chorioamnionitis after any vaccine in the United States during the period from July 1, 1990 through February 2, 2014.

RESULTS

VAERS received 31 reports of chorioamnionitis out of 3389 pregnancy reports in 24 years. The three most common vaccines in these reports were 2009 H1N1 inactivated influenza, quadrivalent human papillomavirus (HPV4), and Tdap vaccines in 32%, 29% and 26% of reports, respectively. Fifty-eight percent of reports had at least one reported risk factor for chorioamnionitis. Chorioamnionitis was identified in 3 reports of spontaneous abortions and 6 stillbirths, 6 reports of preterm birth (two of whom died) and 16 reports of term birth; maternal outcomes included two reports of postpartum hemorrhage and one report of maternal admission to the intensive care unit. No maternal deaths were reported.

CONCLUSION

Chorioamnionitis was found to be uncommonly reported, representing 1% of pregnancy reports to VAERS. A majority of reports had at least one risk factor for chorioamnionitis.

摘要

背景

2012年10月,免疫实践咨询委员会(ACIP)建议在每次妊娠期间接种一剂破伤风类毒素、白喉类毒素减少量和无细胞百日咳疫苗(Tdap),无论该女性既往是否接种过Tdap。一项回顾性队列研究评估了2010 - 2012年期间两个疫苗安全数据链(VSD)站点孕妇接种Tdap疫苗的安全性,发现绒毛膜羊膜炎风险虽小但具有统计学意义的增加。

目的

我们对疫苗不良事件报告系统(VAERS)数据库进行了回顾,以描述接种任何疫苗后绒毛膜羊膜炎的报告情况。

方法

我们在VAERS数据库中搜索了1990年7月1日至2014年2月2日期间美国接种任何疫苗后发生绒毛膜羊膜炎的报告。

结果

在24年的3389份妊娠报告中,VAERS收到了31份绒毛膜羊膜炎报告。这些报告中最常见的三种疫苗分别是2009年甲型H1N1流感灭活疫苗、四价人乳头瘤病毒(HPV4)疫苗和Tdap疫苗,分别占报告的32%、29%和26%。58%的报告至少有一项绒毛膜羊膜炎的报告风险因素。在3例自然流产报告、6例死产报告、6例早产报告(其中2例死亡)和16例足月产报告中发现了绒毛膜羊膜炎;产妇结局包括2例产后出血报告和1例产妇入住重症监护病房的报告。未报告产妇死亡。

结论

发现绒毛膜羊膜炎的报告不常见,占向VAERS报告的妊娠报告的1%。大多数报告至少有一项绒毛膜羊膜炎的风险因素。

相似文献

引用本文的文献

4
Safety of Maternal Immunization Against Pertussis: A Systematic Review.孕妇百日咳免疫接种的安全性:一项系统评价。
Infect Dis Ther. 2019 Dec;8(4):543-568. doi: 10.1007/s40121-019-00265-6. Epub 2019 Sep 17.
7
The safety of maternal immunization.孕产妇免疫接种的安全性。
Hum Vaccin Immunother. 2016 Dec;12(12):3132-3136. doi: 10.1080/21645515.2016.1222341. Epub 2016 Aug 19.

本文引用的文献

9
Inflammatory responses to trivalent influenza virus vaccine among pregnant women.孕妇对三价流感病毒疫苗的炎症反应。
Vaccine. 2011 Nov 8;29(48):8982-7. doi: 10.1016/j.vaccine.2011.09.039. Epub 2011 Sep 22.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验